Clarity Pharmaceuticals (ASX:CU6) FCF Yield %: -10.72 (As of Jun. 28, 2026)


ASX:CU6 Clarity Pharmaceuticals Ltd ASX:CU6
39 GF Score
Price A$1.82
! 2 Warning Signs
View Full Analysis

What is Clarity Pharmaceuticals FCF Yield %?

Clarity Pharmaceuticals ASX:CU6 -11.03% 39 FCF Yield % is -10.72 as of Jun. 28, 2026. GuruFocus rates ASX:CU6 with a GF Score™ of 39/100. The stock has 2 warning signs investors should review. Among 1,416 Biotechnology companies, Clarity Pharmaceuticals ranks worse than 52.33% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Clarity Pharmaceuticals's Trailing 12-Month Free Cash Flow is A$-72.59 Mil, and Market Cap is A$676.94 Mil. Therefore, Clarity Pharmaceuticals's FCF Yield % for today is -10.72%.

The historical rank and industry rank for Clarity Pharmaceuticals's FCF Yield % or its related term are showing as below:

ASX:CU6' s FCF Yield % Range Over the Past 10 Years
Min: -10.72   Med: 0   Max: 0
Current: -10.72

ASX:CU6's FCF Yield % is ranked worse than
52.33% of 1416 companies
in the Biotechnology industry
Industry Median: -9.62 vs ASX:CU6: -10.72

Clarity Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

Clarity Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Clarity Pharmaceuticals FCF Yield % Related Terms

Clarity Pharmaceuticals FCF Yield % Historical Data

* Premium members only.

The historical data trend for Clarity Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clarity Pharmaceuticals FCF Yield % Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23 Jun24 Jun25
FCF Yield %
-10.28 -29.79 -2.59 -6.84

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.39 -1.97 -4.55 -6.11 -7.64

ASX:CU6 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Clarity Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarity Pharmaceuticals FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clarity Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Clarity Pharmaceuticals's FCF Yield % falls into.


ASX:CU6
39GF Score
Clarity Pharmaceuticals Ltd ASX:CU6
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clarity Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Clarity Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-54.952 / 803.68
=-6.84%

Clarity Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-48.052 * 2 / 1257.4614
=-7.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -10.72 mean?
Clarity Pharmaceuticals (ASX:CU6) has a FCF Yield % of -10.72 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clarity Pharmaceuticals and its competitors. According to the industry distribution chart, Clarity Pharmaceuticals ranks #741 out of 1416 companies in the Biotechnology industry, placing it in the top 52.3%.
Is Clarity Pharmaceuticals' FCF Yield % too high?
Clarity Pharmaceuticals' current FCF Yield % is -10.72. Based on the distribution chart, Clarity Pharmaceuticals ranks #741 out of 1416 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Clarity Pharmaceuticals has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Clarity Pharmaceuticals' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Clarity Pharmaceuticals ranks #741 out of 1416 companies for FCF Yield %. This places Clarity Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clarity Pharmaceuticals and its competitors. Clarity Pharmaceuticals's current FCF Yield % is -10.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clarity Pharmaceuticals stock overvalued right now?
Clarity Pharmaceuticals (ASX:CU6) has a current FCF Yield % of -10.72. The current FCF Yield % is -10.72. Clarity Pharmaceuticals' overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Clarity Pharmaceuticals (ASX:CU6), the current FCF Yield % is -10.72 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clarity Pharmaceuticals Business Description

Other Exchanges CLRPF:USA1F4:Germany
Address 2-4 Cornwallis Street, Suite 212a, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, using its SAR Technology platform. Clarity's Targeted Copper Theranostic (TCT) platform of products utilize pairing of copper isotopes, specifically copper-64 (Cu-64 or 64Cu) for imaging and copper-67 Cu-67 or 67Cu) for therapy, which delivers accuracy and precision in the treatment of a range of cancers. The company's clinical development pipeline includes SAR-bisPSMA, SAR-Bombesin, and Sartate, in their different stages of development for the diagnosis and/or treatment of various cancers. Clarity operates in a single segment, which is the development of radiopharmaceuticals. Geographically, it operates in Australia and the United States.
39GF Score

Get the complete analysis for ASX:CU6

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.82
Price